Zdrowie i gospodarka · 09/09/2022

FDA Releases Draft Guidance on Quantitative Labeling of Sodium, Potassium, and Phosphorus in Over-the-Counter and Prescription Drugs

The FDA has made available a draft guidance to help pharmaceutical companies accurately label the amounts of sodium, potassium, and phosphorus in their human over-the-counter and prescription medications.